deriglidole

a selective peripheral alpha2-adrenoceptor antagonist

Also Known As:

SL 86-0175; SL 86.0175; SL-86.0175

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

1.	Hyperglycemia 12/01/1995 - "Deriglidole antagonized the reduction of insulin secretion and the hyperglycemia induced by UK-14.304. " 01/01/1998 - "In the present study, we showed, in vivo in mice, that SL84.0418 and deriglidole potently reduced glycemia and antagonized diazoxide-induced hyperglycemia, whereas SL86.0714 and tolbutamide were markedly less potent. "